Shares of Nephrocare Health Services Ltd. made a positive start on the stock market on Tuesday. The stock listed at around 7 percent above its IPO price, signalling steady investor confidence.
On the NSE, Nephrocare shares opened near ₹490, while on the BSE they listed at about ₹491.70. The IPO price was fixed at ₹460 per share. The listing was in line with market expectations and supported by stable overall market conditions.
The company’s ₹871-crore IPO saw strong interest from investors. The issue was subscribed more than 14 times. Institutional investors led the demand, showing confidence in the company’s long-term prospects. Participation from non-institutional investors was also healthy. Retail demand remained moderate.
Nephrocare Health Services is a leading provider of dialysis care in India. It operates under the NephroPlus brand. The company runs one of the largest organised dialysis networks in the country, with over 500 centres across India and a presence in select international markets. Its centres operate both within hospitals and as standalone units.
The IPO included a fresh issue of shares and an offer for sale by existing shareholders. Funds raised from the fresh issue will be used mainly to reduce debt, improve the balance sheet, and support the expansion of dialysis centres. A portion will also be used for general corporate needs.
Market experts said the steady listing reflects cautious optimism around healthcare service companies. Such businesses offer predictable demand and long-term growth potential. However, future performance will depend on execution, cost control, and the pace of expansion.
For investors who received shares, the listing delivered immediate gains. Going forward, the stock’s movement will be shaped by earnings growth, expansion plans, and broader market sentiment.Also Read: KSH International IPO subscribed 21% on day 2